Legal Representation
Attorney
Michael J. Bevilacqua, Esquire
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| May 2, 2008 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| May 2, 2008 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Jan 11, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 26, 2007 | ALIE | A | ASSIGNED TO LIE |
| Sep 26, 2007 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED |
| Sep 25, 2007 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Sep 25, 2007 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Sep 25, 2007 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Sep 21, 2007 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 22, 2007 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
chemical additives for use in the manufacture of therapeutic pharmaceuticals, chemical reagents for scientific or medical research use; and chemicals and biochemicals, namely enzymes for use as reagents and biochemical research and diagnostic applications in industry, agriculture and forestry
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001